Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2024

Open Access 01.12.2024 | Research

Conformal thyroidectomy is a feasible option in papillary thyroid microcarcinoma: a retrospective cohort study with 10-year follow-up results

verfasst von: Chen Li, Jian Cao, Guo-Shuai Chen, Xiao-Dong Yang, Ke-Wei Jiang, Ying-Jiang Ye

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2024

Abstract

Background

In recent years, there has been an increasing prevalence of patients with papillary thyroid microcarcinoma (PTMC) without lymph node involvement in medical centers worldwide. For patients who are unable to undergo active surveillance (AS) and are afraid of postoperative complications, conformal thyroidectomy may be a suitable option to ensure both preservation of function and complete removal of the tumor.

Methods

The patients in the cohort during 2010 to 2015 were retrospectively enrolled strictly following the inclusion and exclusion criteria. The observation and control groups were defined based on the surgical approach, with patients in the observation group undergoing conformal thyroidectomy and patients in the control group undergoing lobectomy. Event-free survival (EFS), the interval from initial surgery to the detection of recurrent or metastatic disease, was defined as the primary observation endpoint.

Results

A total of 319 patients were included in the study, with 124 patients undergoing conformal thyroidectomy and 195 patients undergoing lobectomy. When compared to lobectomy, conformal thyroidectomy demonstrated reduced hospital stays, shorter operative times, and lower rates of vocal cord paralysis and hypoparathyroidism. Furthermore, the mean bleeding volume during the operation and the rate of permanent hypothyroidism were also lower in the conformal thyroidectomy group than in the lobectomy group. However, there was no statistically significant difference observed in the 5- and 10-year EFS between the two groups.

Conclusions

Conformal thyroidectomy had advantages in perioperative management and short-term complication rates, with an EFS that was not inferior to that of lobectomy. Thus, conformal thyroidectomy is a feasible option for low-risk PTMC patients.
Hinweise

Supplementary information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00423-024-03333-9.
Ying-Jiang Ye and Ke-Wei Jiang contributed equally to this work.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Papillary thyroid microcarcinoma (PTMC) is defined by the WHO as papillary thyroid cancer with a maximum diameter of 1.0 cm [1]. The incidence of PTMC has increased rapidly and constitutes more than 50% of new thyroid cancer cases [24], gradually becoming the main disease component of patients in thyroid medical centers, especially PTMC with no concerning lymph nodes.
Active surveillance (AS) and surgery are two selective choices for PTMC patients without concern for lymph nodes. Referring to guidelines published by the American Thyroid Association (ATA) [5], National Comprehensive Cancer Network (NCCN) [6], European Society for Medical Oncology (ESMO) [7], and other thyroid associations in China, Korea [8], etc., lobectomy was the preferred surgical approach. AS was a selective choice for low-risk PTMC patients with good compliance, especially after the report of approximately 30-year follow-up results of PTMC patients who underwent AS in Kuma Hospital [9] and recommendations by Japanese guidelines. In addition, some researchers [10, 11] attempted to complete radical treatment of PTMC by RFA and obtained acceptable results.
On one hand, patients in specific occupations requiring frequent use of the voice, such as teachers, singers, moderators, commentators, worry about the progression of tumor, and on the other hand, the vocal fold paralysis (VFP) will seriously affect their careers. Moreover, young female patients with reproductive needs usually cannot accept and worry about hypothyroidism after lobectomy or total thyroidectomy (TT) [12]. Thus, for low-risk patients with specific needs, we conducted modified partial thyroidectomy, also called conformal thyroidectomy, and obtained better short-term outcomes and similar long-term oncological outcomes compared with lobectomy. Following the transformation from total thyroidectomy to lobectomy, we hope that this study will provide evidence for the feasibility of conformal thyroidectomy and contribute to minimally invasive thyroid surgery and functional protection.

Methods

Definition

The definition of conformal thyroidectomy was as follows: (1) preoperative ultrasound (and intraoperative ultrasound) located the peripheral margin of tumor; (2) it was ensured that the margin was more than 5 mm from the tumor; (3) intraoperative freeze biopsy proved that the margin was negative.

Study design and patients

This retrospective study was conducted at Peking University People's Hospital, a single tertiary medical center, from 2010 to 2015. All patients were fully informed about the extent, benefits, and risks of the surgery and signed the informed consent form. The Institutional Review Board of Peking University People's Hospital provided ethical approval (2023PHB289-001) and approved the data collection and subsequent analyses in accordance with the Declaration of Helsinki, as revised in 2013. The study adheres to the STROCSS 2021 Guideline [13].
The inclusion criteria were as follows: (1) fine-needle aspiration (FNA) biopsy result was papillary thyroid cancer; (2) the stage was cT1aN0M0 according to 8th edition American Joint Committee on Cancer Staging (AJCC) [14]; and (3) there were no other severe disease or malignant tumors that threatened life.
The exclusion criteria were as follows: (1) bilateral thyroid cancer; (2) prior radiation exposure of the head and neck; (3) poorly differentiated and other poor prognosis subtypes; and (4) tumors located in specific sites for which it was difficult to ensure margins, such as the entry point of the recurrent laryngeal nerve (RLN), or other invasive prognostic factors [15, 16].
The patients who underwent conformal thyroidectomy were enrolled in the observation group, and patients who underwent lobectomy without lymph node dissection were enrolled in the control group.

Management of follow-up

Regardless of their surgical extent, all patients were followed with physical examinations, thyroid function tests, and neck ultrasonography every 3 months. All considerations of recurrence and metastasis by ultrasound were checked by a senior radiologist, and controversy was judged by the third radiologist and surgeon who conducted the surgery. Neck and chest computed tomography with contrast, FNA, and whole-body fluorodeoxyglucose positron emission tomography were recommended if the patients considered recurrence of metastasis.

Primary outcome

The primary outcome of this study was recurrence and metastasis, defined as new lesions after surgery confirmed by cytological or histopathological examination and/or the appearance of distant metastatic lesions on imaging studies. Event-free survival (EFS), the interval from initial surgery to the detection of recurrent or metastatic disease, was compared between groups formed according to the surgical extent.

Statistical analysis

R 4.3.1 (R Foundation for Statistical Computing, Vienna, Austria; www.​Rroject.​org) and SPSS 29.0 (IBM, Armonk, NY, United States) were used for data analysis. Categorical variables were analyzed using Pearson’s χ2 test or Fisher’s exact test, according to the expected values. The Mann–Whitney U test was utilized to compare continuous variables, which are presented as medians and interquartile ranges and as the mean ± SD. The Kaplan–Meier method and log-rank test were performed to conduct survival analyses and evaluate differences in survival time, respectively. Univariate and multivariate analyses were performed using the Cox proportional hazards model. Univariate analysis was primarily performed, and variables with P < 0.2 were subsequently input into the multivariate analysis to determine the independent prognostic factors. Hazard ratios with their 95% confidence intervals were also derived. Statistical significance was defined as P < 0.05. EFS curves were constructed using the Kaplan–Meier method, and the log-rank test was used to compare EFS.

Results

Baseline clinical characteristics

As shown in Table 1, a total of 124 of 319 patients were enrolled in the observation group, and 195 patients were enrolled in the control group according to the surgical extent. The mean age of the patients was 49.52(± 12.50) and 47.78(± 13.10) years old in the two groups, and female patients comprised the majority (77.42% and 78.46%, respectively). Regarding tumor site and size, lesions had a mean diameter of 0.62(± 0.28) and 0.62(± 0.28) cm, and most of them were located equally in the left and right lobes in the two groups, except for six located in the isthmus (two in the observation group and four in the control group). There was no significant difference between the observation and control groups in the above four items.
Table 1
Baseline characteristics of total patients
 
Observation Group
(n = 124)
Control Group
(n = 195)
p-Value
Age (years)
49.52(± 12.50)
47.78(± 13.10)
0.239
Gender
  
0.936
  Female
96
153
 
  Male
28
42
 
Tumor Site
  
0.881
  Left lobe
63
94
 
  Right lobe
59
97
 
  Isthmus
2
4
 
Tumor Size (cm)
0.62(± 0.28)
0.62(± 0.29)
0.958

Perioperative characteristics

Following Table 2, the differences in hospital stays (0.61 days, 6.48(± 2.24) in observation group and 7.09(± 2.11) in control group), operative time (50.8 min, 42.15(± 9.35) in observation group and 92.95(± 46.35) in control group), and short-term complications (4.03%, 1.61% in observation group and 6.67% in control group) were statistically significant between the two groups. Regarding the mean bleeding volume, the loss in the observation group was 2.34 mL less than that in the control group, with no statistical significance. Interestingly, patients who underwent conformal thyroidectomy had fewer short-term complications, and only two cases of postoperative bleeding were observed. In the control group, although most patients had no long-term complications (after 10 years of follow-up, two patients suffered from persistent vocal cord paralysis, and no other long-term complications were observed), approximately 5% of them suffered from thyroidectomy-related complications and other perioperative complications (three patients were observed, one for pneumonia and two for cardiocerebrovascular accident). In addition, after 5 years of thyroid hormone replacement treatment, three patients suffered from permanent hypothyroidism in the lobectomy group, and no patients were observed in the conformal thyroidectomy group.
Table 2
Perioperative characteristics of total patients
 
Observation Group
(n = 124)
Control Group
(n = 195)
p-Value
Hospital stays (days)
6.48(± 2.24)
7.09(± 2.11)
0.015
Operative time (minutes)
42.15(± 9.35)
92.95(± 46.35)
< 0.001
Bleeding volume (mL)
17.30(± 14.94)
19.64(± 15.23)
0.178
Short-term complications
2 (1.61%)
13 (6.67%)
0.038
  Bleeding
2
1
 
  Hypoparathyroidism
0
4
 
  Vocal cord paralysis
0
5
 
  Others
0
3
 
Permanent hypothyroidism
0
3
0.428

Follow-up results

After ten years of follow-up(119.17(± 24.58) month in observation group and 120.10(± 25.74) in control group), all the patients survived, and nine in the observation group and 16 in the control group had recurrence or metastasis (Table 3).
Table 3
Follow-up results of total patients
 
Observation Group
(n = 124)
Control Group
(n = 195)
p-Value
Follow-up times (months)
119.17(± 24.58)
120.10(± 25.74)
0.775
Outcome
9
16
 
Lobe Recurrence
1
1
 
  Ipsilateral
0
0
 
  Contralateral
1
1
 
  Bilateral
0
0
 
Lymph nodes metastasis
9
15
 
  Central neck region
4
5
 
    Ipsilateral
4
4
 
    Contralateral
0
0
 
    Bilateral
0
1
 
  Lateral cervical region
5
10
 
    Ipsilateral
4
6
 
    Contralateral
0
1
 
    Bilateral
1
3
 
In patients who underwent conformal thyroidectomy, one patient had a new lesion in the contralateral lobe and ipsilateral lateral cervical lymph node, four patients had central neck lymph node metastasis, and four patients had cervical lymph node metastasis. In patients with lobectomy, one patient had a new lesion in the contralateral lobe, five patients had central neck lymph node metastasis, and ten patients had lateral lymph node metastasis. Another notable observation is that a total of five patients (one in the observation group and four in the control group) showed invasive behavior, evidenced by bilateral lymph node metastases. The 5- and 10-year EFS rates were 92.8% and 87.9% in the observation group and 93.3% and 91.7% in the control group, respectively, and there was no statistical significance between the two groups (p = 0.776, Fig. 1).

Discussion

With increasing published evidence, most guidelines have demonstrated that lobectomy, instead of radioactive iodine (RAI) and TT, should become the first-line treatment for low-risk PTMC. A lower risk of complications, less hormone replacement, and an acceptable recurrence rate facilitated the acceptance of lobectomy [8, 17].
In other words, according to published records, the incidence of thyroidectomy-related lawsuits in America was 0.059% [18]. Among them, except for death due to hematoma, long-term complications such as nerve injury, especially recurrent laryngeal nerve (RLN), and hypoparathyroidism were the primary causes [19, 20]. Complications of TT and lobectomy constituted the notable percentage of 66.40%, and only a small fraction comprised by less invasive surgical procedures such as subtotal thyroidectomy and partial thyroidectomy [20].
For thyroid cancer, which had longer survival than other cancers, it seems that complications rather than recurrence, metastasis, and tumor-related death affected patient satisfaction to some degree. Thus, for patients with the specific needs mentioned above, a less invasive surgical approach instead of lobectomy was feasible and met their needs.
Based upon the same baseline characteristics with no significant difference, conformal thyroidectomy showed advantages in hospital stays, operative time, and short-term complications. According to published records, shorter hospital stays are usually associated with higher patient satisfaction and lower inpatient expenses [21]. A shorter operative time could enhance recovery after surgery and reduce anesthesia and circulatory complications. Compared with published studies [22], the complication rate in our center was acceptable; even better, postoperative bleeding was observed in two patients in the conformal thyroidectomy group and one patient in the control group, and hypoparathyroidism and VFP only occurred in the control group. Because the posterior structure of the thyroid was not exposed, conformal thyroidectomy demonstrated desirable protection of the RLN and parathyroids. In addition, consistent with the published literature [23], three patients with permanent hypothyroidism were observed in the control group, and conformal thyroidectomy reduced the rate of hypothyroidism.
Compared with previous studies [24], there was no significant difference in long-term follow-up results (10-year EFS in patients who underwent lobectomy was 92% from the literature vs. 91.7% from our studies). Although there were no criteria for the surgical margin in thyroidectomy and some studies [25] demonstrated that a positive margin was not an independent risk factor, we still chose 5 mm as the safe margin, and our study proved that radical resection with a safe margin was as safe as lobectomy. Although most PTMCs carry an excellent prognosis, some lesions display aggressive behavior (central neck, lateral cervical lymph node metastasis or distant metastasis) and fatal outcomes [26, 27]. Concerning relapsed patients, LN metastasis made up the majority, especially ipsilateral central neck and lateral cervical LNs. Interestingly, the recurrence pattern was different from that in previous studies [28], and other possible reasons, such as preoperative micrometastasis, need to be clarified. Moreover, conformal thyroidectomy gave us a glimpse at a novel surgical approach and the definition of a safe margin in thyroid cancer.
One decade ago, TT was the standard surgical approach, and conformal thyroidectomy was just an experimental surgical approach for patients with specific needs. Thus, the study was retrospective design, and the patients were not enrolled randomly. Fortunately, there were no differences between the groups in baseline characteristics, and no steps needed to be taken (such as propensity score matching) to eliminate them.

Conclusions

As a novel treatment strategy, conformal thyroidectomy had an EFS that was not inferior to that of lobectomy but showed advantages in perioperative management and short-term complication rates. Compared with RFA, conformal thyroidectomy seems not to offer any advantages in perioperative characteristics or short- or long-term outcomes. However, the shorter learning curve and lower learning barrier of conformal thyroidectomy make it suitable for promotion in countries/areas with no developed healthcare services.

Acknowledgements

We thank for Peking University Library Database which provided access of literature research, and the help from my wife Meng-Meng Zhang. Moreover, all the authors paid tribute to all the patients involved in this study.

Declarations

The Institutional Review Board of Peking University People’s Hospital provided ethical approval (2023PHB289-001) and approved the data collection and subsequent analyses in accordance with the Declaration of Helsinki as revised in 2013. Written informed consent from all patients was obtained before the operation.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Anhänge

Supplementary information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911 Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911
2.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249CrossRefPubMed
3.
Zurück zum Zitat Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225–234CrossRefPubMed Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225–234CrossRefPubMed
4.
Zurück zum Zitat Megwalu UC, Moon PK (2022) Thyroid cancer incidence and mortality trends in the United States: 2000–2018. Thyroid 32:560–570CrossRefPubMed Megwalu UC, Moon PK (2022) Thyroid cancer incidence and mortality trends in the United States: 2000–2018. Thyroid 32:560–570CrossRefPubMed
5.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A (2019) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 30:1856–1883CrossRefPubMed Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A (2019) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 30:1856–1883CrossRefPubMed
8.
Zurück zum Zitat Song E, Han M, Oh HS, Kim WW, Jeon MJ, Lee YM, Kim TY, Chung KW, Kim WB, Shong YK et al (2019) Lobectomy is feasible for 1–4 cm papillary thyroid carcinomas: a 10-year propensity score matched-pair analysis on recurrence. Thyroid 29:64–70CrossRefPubMed Song E, Han M, Oh HS, Kim WW, Jeon MJ, Lee YM, Kim TY, Chung KW, Kim WB, Shong YK et al (2019) Lobectomy is feasible for 1–4 cm papillary thyroid carcinomas: a 10-year propensity score matched-pair analysis on recurrence. Thyroid 29:64–70CrossRefPubMed
9.
Zurück zum Zitat Miyauchi A, Ito Y, Fujishima M, Miya A, Onoda N, Kihara M, Higashiyama T, Masuoka H, Kawano S, Sasaki T et al (2023) Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid 33:817–825CrossRefPubMedPubMedCentral Miyauchi A, Ito Y, Fujishima M, Miya A, Onoda N, Kihara M, Higashiyama T, Masuoka H, Kawano S, Sasaki T et al (2023) Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk papillary thyroid microcarcinoma: 30-year experience. Thyroid 33:817–825CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ding M, Tang X, Cui D, Chi J, Shi Y, Wang T, Zhai B, Li P (2019) Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol 74:712–717CrossRefPubMed Ding M, Tang X, Cui D, Chi J, Shi Y, Wang T, Zhai B, Li P (2019) Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol 74:712–717CrossRefPubMed
11.
Zurück zum Zitat Yan L, Li Y, Li XY, Xiao J, Tang J, Luo Y (2023) Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: a retrospective study with more than 5 years of follow-up. Cancer 129:2469–2478CrossRefPubMed Yan L, Li Y, Li XY, Xiao J, Tang J, Luo Y (2023) Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: a retrospective study with more than 5 years of follow-up. Cancer 129:2469–2478CrossRefPubMed
12.
Zurück zum Zitat van Velsen EFS, Leung AM, Korevaar TIM (2022) Diagnostic and treatment considerations for thyroid cancer in women of reproductive age and the perinatal period. Endocrinol Metab Clin North Am 51:403–416CrossRefPubMed van Velsen EFS, Leung AM, Korevaar TIM (2022) Diagnostic and treatment considerations for thyroid cancer in women of reproductive age and the perinatal period. Endocrinol Metab Clin North Am 51:403–416CrossRefPubMed
13.
Zurück zum Zitat Mathew G, Agha R, Albrecht J, Goel P, Mukherjee I, Pai P, D’Cruz AK, Nixon IJ, Roberto K, Enam SA et al (2021) STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 96:106165CrossRefPubMed Mathew G, Agha R, Albrecht J, Goel P, Mukherjee I, Pai P, D’Cruz AK, Nixon IJ, Roberto K, Enam SA et al (2021) STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 96:106165CrossRefPubMed
14.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99 Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99
15.
Zurück zum Zitat Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35CrossRefPubMed Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35CrossRefPubMed
16.
Zurück zum Zitat Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, Miya A (2016) Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg 40:523–528CrossRefPubMed Ito Y, Miyauchi A, Oda H, Kobayashi K, Kihara M, Miya A (2016) Revisiting low-risk thyroid papillary microcarcinomas resected without observation: was immediate surgery necessary? World J Surg 40:523–528CrossRefPubMed
17.
Zurück zum Zitat Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L et al (2022) Thyroidectomy without radioiodine in patients with low-risk thyroid cancer. N Engl J Med 386:923–932CrossRefPubMed Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L et al (2022) Thyroidectomy without radioiodine in patients with low-risk thyroid cancer. N Engl J Med 386:923–932CrossRefPubMed
18.
Zurück zum Zitat Singer MC, Iverson KC, Terris DJ (2012) Thyroidectomy-related malpractice claims. Otolaryngol Head Neck Surg 146:358–361CrossRefPubMed Singer MC, Iverson KC, Terris DJ (2012) Thyroidectomy-related malpractice claims. Otolaryngol Head Neck Surg 146:358–361CrossRefPubMed
19.
Zurück zum Zitat Abadin SS, Kaplan EL, Angelos P (2010) Malpractice litigation after thyroid surgery: the role of recurrent laryngeal nerve injuries, 1989–2009. Surgery 148:718–722; discussion 722–713 Abadin SS, Kaplan EL, Angelos P (2010) Malpractice litigation after thyroid surgery: the role of recurrent laryngeal nerve injuries, 1989–2009. Surgery 148:718–722; discussion 722–713
20.
Zurück zum Zitat Gartland RM, Bloom JP, Parangi S, Hodin R, DeRoo C, Stephen AE, Narra V, Lubitz CC, Mort E (2019) A long, unnerving road: malpractice claims involving the surgical management of thyroid and parathyroid disease. World J Surg 43:2850–2855CrossRefPubMed Gartland RM, Bloom JP, Parangi S, Hodin R, DeRoo C, Stephen AE, Narra V, Lubitz CC, Mort E (2019) A long, unnerving road: malpractice claims involving the surgical management of thyroid and parathyroid disease. World J Surg 43:2850–2855CrossRefPubMed
21.
Zurück zum Zitat Dionigi G, Bacuzzi A, Rovera F, Boni L, Piantanida E, Tanda ML, Castano P, Annoni M, Bartalena L, Dionigi R (2008) Shortening hospital stay for thyroid surgery. Expert Rev Med Devices 5:85–96CrossRefPubMed Dionigi G, Bacuzzi A, Rovera F, Boni L, Piantanida E, Tanda ML, Castano P, Annoni M, Bartalena L, Dionigi R (2008) Shortening hospital stay for thyroid surgery. Expert Rev Med Devices 5:85–96CrossRefPubMed
22.
Zurück zum Zitat Hsiao V, Light TJ, Adil AA, Tao M, Chiu AS, Hitchcock M, Arroyo N, Fernandes-Taylor S, Francis DO (2022) Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 148:531–539CrossRefPubMedPubMedCentral Hsiao V, Light TJ, Adil AA, Tao M, Chiu AS, Hitchcock M, Arroyo N, Fernandes-Taylor S, Francis DO (2022) Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 148:531–539CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Johner A, Griffith OL, Walker B, Wood L, Piper H, Wilkins G, Baliski C, Jones SJ, Wiseman SM (2011) Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a clinical algorithm. Ann Surg Oncol 18:2548–2554CrossRefPubMed Johner A, Griffith OL, Walker B, Wood L, Piper H, Wilkins G, Baliski C, Jones SJ, Wiseman SM (2011) Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a clinical algorithm. Ann Surg Oncol 18:2548–2554CrossRefPubMed
24.
Zurück zum Zitat van Gerwen M, Alsen M, Lee E, Sinclair C, Genden E, Taioli E (2021) Recurrence-free survival after total thyroidectomy and lobectomy in patients with papillary thyroid microcarcinoma. J Endocrinol Invest 44:725–734CrossRefPubMed van Gerwen M, Alsen M, Lee E, Sinclair C, Genden E, Taioli E (2021) Recurrence-free survival after total thyroidectomy and lobectomy in patients with papillary thyroid microcarcinoma. J Endocrinol Invest 44:725–734CrossRefPubMed
25.
Zurück zum Zitat Back K, Kim SK, Chai YJ, Kim J-H, Choe J-H, Kim JS (2019) Does microscopic positive tumor margin in papillary thyroid cancer really matter? Surgery 166:1160–1167CrossRefPubMed Back K, Kim SK, Chai YJ, Kim J-H, Choe J-H, Kim JS (2019) Does microscopic positive tumor margin in papillary thyroid cancer really matter? Surgery 166:1160–1167CrossRefPubMed
26.
Zurück zum Zitat Ghossein R, Ganly I, Biagini A, Robenshtok E, Rivera M, Tuttle RM (2014) Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Thyroid 24:245–253CrossRefPubMed Ghossein R, Ganly I, Biagini A, Robenshtok E, Rivera M, Tuttle RM (2014) Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Thyroid 24:245–253CrossRefPubMed
27.
Zurück zum Zitat Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J (2013) Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol 44:556–565CrossRefPubMed Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J (2013) Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol 44:556–565CrossRefPubMed
28.
Zurück zum Zitat van Dijk SPJ, Coerts HI, Loncar I, Verhoef C, Kruijff S, Engelsman AF, Peeters RP, van Ginhoven TM (2023) Deescalating follow-up after hemithyroidectomy for patients with low-risk papillary thyroid microcarcinoma. JAMA Otolaryngol Head Neck Surg 149:42–48CrossRefPubMed van Dijk SPJ, Coerts HI, Loncar I, Verhoef C, Kruijff S, Engelsman AF, Peeters RP, van Ginhoven TM (2023) Deescalating follow-up after hemithyroidectomy for patients with low-risk papillary thyroid microcarcinoma. JAMA Otolaryngol Head Neck Surg 149:42–48CrossRefPubMed
Metadaten
Titel
Conformal thyroidectomy is a feasible option in papillary thyroid microcarcinoma: a retrospective cohort study with 10-year follow-up results
verfasst von
Chen Li
Jian Cao
Guo-Shuai Chen
Xiao-Dong Yang
Ke-Wei Jiang
Ying-Jiang Ye
Publikationsdatum
01.12.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2024
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-024-03333-9

Weitere Artikel der Ausgabe 1/2024

Langenbeck's Archives of Surgery 1/2024 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.